4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-016930
Director acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fust Matthew K Director | 2022-03-04 | Option exercise | +7,500 | $40.37 | $302,775 | 23,195 | D |
| Derivatives | |||||||
| Fust Matthew K Director | 2022-03-04 | Option exercise · Stock Option (Right to Buy) | −7,500 | 0 | D | ||
Loading xslF345X03/doc4.xml…